Bioassay guided fractionation of the dichloromethane extract of the underground parts of Gethyllis ciliaris, using a cyclooxygenase-1 enzyme assay, has resulted in the isolation of the dihydroxydimethylbenzopyran-4-one isoeugenitol 1 (IC 50 = 262 μM). The 90% methanolic extract yielded 9Z-octadec-9-enamide 3 and the novel compound isoeugenitol glycoside 2. The structures of the isolated compounds have been assigned on the basis of spectral analysis, including 1D and 2D NMR techniques.
Introduction
The genus Gethyllis L. (Amaryllidaceae) comprises some 32 species in southern Africa, where they are found mainly in Namibia and the Northern and Western Cape Provinces of South Africa (Du Plessis and Duncan, 1989) . Many species of the genus are considered to be endangered (Van Wyk et al., 1997) .
The fruit pods of many Gethyllis species are boiled or administered as an alcohol infusion for stomach disorders, while flower decoctions are used for toothache (Van Wyk et al., 1997; Louw et al., 2002) . Gethyllis ciliaris L. in particular is used in South African traditional medicine as a remedy for colic, flatulence and indigestion (Watt and Breyer-Brandwijk, 1962) .
The dichloromethane extract of the roots and bulbs of G. ciliaris have previously been shown to display anti-inflammatory activity in the cyclooxygenase-1 and-2 (COX-1 and COX-2) assays (Elgorashi and Van Staden, 2004) . No reports on the chemistry or biological activity of compounds isolated from species of the genus have previously appeared (Dictionary of Natural Products, 2006) .
The enzyme cyclooxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of the pro-inflammatory prostaglandins. Three forms of cyclooxygenase (COX) have been described: A constitutive COX-1 enzyme present in most cells and tissues; an inducible (COX-2) isoenzyme observed in many cells in response to pro-inflammatory cytokines; and a COX-1 variant protein, named COX-3, which is sensitive to acetaminophen. Non-steroidal anti-inflammatory drugs (NSAIDs) block cyclooxygenase and consequently prevent the biosynthesis of prostaglandins. Increasing the selectivity of NSAIDs to COX-1 and COX-2 enzymes increases damage to the gastrointestinal tract and heart muscle respectively (Botting, 2006) .
The aims of this study were to determine the degree of antiinflammatory activity of the underground parts of G. ciliaris and to identify the chemical constituents in the extracts.
Materials and methods

Plant material
Whole plants of G. ciliaris L., obtained from Summerfield's Indigenous Bulbs and Seeds, Cape Town, were identified by Professor T.J. Edwards of the University Herbarium, University of KwaZulu-Natal, Pietermaritzburg. A voucher specimen was prepared (Elgorashi NU7) and is deposited at the University Herbarium.
Extraction and isolation
The air-dried and powdered underground parts (bulbs and roots, 276 g) were sequentially extracted, three times each for 24 h respectively, with CH 2 Cl 2 and MeOH (90%) (each 3 × 2 L), and the combined solvents evaporated under reduced pressure at 30°C. Vacuum liquid chromatography (VLC) (150 g Merck 9385 silica gel) of the CH 2 Cl 2 extract (27 g), using a hexane: EtOAc step gradient, was performed. Initially, 100% hexane was used, and then reduced to 10% hexane in 10% increments. Ten fractions were collected and each tested for cyclooxygenase-1 (COX-1) inhibitory activity. The fraction which eluted with 60% hexane was the only active fraction and afforded compound 1 (52 mg), which was recrystallized from CH 2 Cl 2 (Fig. 1) .
The 90% aqueous MeOH extract (34.5 g) was dissolved in acetic acid (0.67 M, 200 mL), extracted with Et 2 O (3 × 50 ml), basified with NH 4 OH (aq, 1 M), extracted with Et 2 O, EtOAc, and Bu n OH (each 3 × 50 mL), and the combined solvents each evaporated under reduced pressure to give fractions A (402 mg), B (338 mg) and C (4.28 g) respectively.
Column chromatography of fraction C using a CH 2 Cl 2 :MeOH step gradient (49:1 to 2:3), afforded seven fractions. Compound 2 (76 mg) crystallized directly from fraction 2, while preparative TLC (Merck glass plates, 20 × 20 cm, silica gel 60 F 254 , 0.25 mm) of fractions 1 and 3, using CH 2 Cl 2 :MeOH (37:3 and 18:3) as solvent systems, respectively, gave compound 3 (5.5 mg).
Cyclooxygenase-1 assay
Anti-inflammatory activity was determined using the COX-1 bioassay, which was carried out according to the method described by Jäger et al. (1996) . The COX-1 enzyme (isolated from ram seminal vesicles) (Sigma-Aldrich) was activated with co-factor solution and pre-incubated on ice for 5 min. The enzyme/co-factor solution (60 μL) was added to 20 μL of test solution (2.5 μL of an ethanolic solution of the compound in 17.5 μL water) and pre-incubated for 5 min at room temperature. [
14 C]Arachidonic acid (20 μL) was added to the test samples and incubated at 37°C for 10 min. After incubation, the reaction was terminated by adding 10 μL 2N HCl. Four controls were run; two background samples, in which the enzyme was inactivated with HCl before the addition of [ 14 C]arachidonic acid, and two solvent blanks. Indomethacin was included as a standard. Percentage inhibition of the tested compound was calculated by comparing the amount of radioactivity present in the sample to that in the solvent blank. IC 50 values were calculated from at least three concentrations using regression analysis.
Results and discussion
Analysis of the NMR spectra of compounds 1 and 2 revealed them to be closely related, with 2 being the glycoside of 1. Compound 1 was identified as dihydroxydimethylbenzopyran-4-one isoeugenitol by comparison of its 1 H and 13 C NMR spectral data with the literature values of the closely related dimethyl ether isoeugenitin methyl ether (Kalinin and Snieckus, 1998) , and by analysis of its 2D (HSQC, HMBC, COSY and NOESY) NMR spectra. The glycoside was placed at C-5 in compound 2 by analysis of the NOESY spectrum, in which a correlation was observed between the glycoside anomeric H-1′ proton signal and that of H-6, but not between H-1′ and the 3H-9 singlet signal of the methyl group at C-8, while the signals of the remaining sugar protons (identified by a series of correlations, in the COSY spectrum, from H-1′) all displayed coupling constants characteristic of trans-coupling, establishing the sugar itself as glucose.
The third compound was identified as 9Z-octadec-9-enamide 3 by analysis of its mass and NMR spectra. In particular, comparison of the 13 C signals for C-9 and C-10 (δ C 129.7, 130.0) in compound 3 with the corresponding parent acids oleic acid (9Z, 129.7, 130.0) and eladaic acid (9E, 130.1, 130.5) showed 3 to be the 9Z isomer. Any influence exerted by the amide group on these values can be discounted on observation that the values for E-vaccenic acid and its corresponding methyl ester, at δ C 130.3 and 130.4, are identical (Aldrich Library of 13C and 1H FT NMR Spectra, 1993) .
Evidence suggests that over-expression of cyclooxgenase enzyme is strongly related to the pathophysiology of inflammation. In our continuous search for cyclooxygenase inhibitors from natural sources, we investigated extracts of G. ciliaris for activity against COX-1 enzyme. The preliminary screening of dichloromethane and 90% methanolic extracts of the underground parts of G. ciliaris for COX-1 inhibitory activity revealed that dichloromethane extracts were significantly more active compared to the 90% methanol extracts (Table 1) . Hence, bioassay guided fractionation was carried out on this extract, Fig. 1. Structures of compounds 1, 2 and 3 isolated from G. ciliaris bulbs and roots. giving isoeugenitol 1 as the COX-1 inhibitor in a dose dependent manner (IC 50 = 262 ± 3.8 μM). For the indomethacin standard the IC 50 was 3.1 + 0.11 μM. The 90% methanolic extract yielded isoeugenitol glycoside 2 and 9Z-octadec-9-enamide 3.
Compounds 1, 2 and 3 are now reported for the first time from G. ciliaris. However, isoeugenitol and its 7-methyl ether isoeugenitin were originally reported from Eugenia caryophyllata Thunb. Bolleter, 1949, 1950) . The latter compound was recently found to induce fruiting of the body of the myxobacteria Stigmatella aurantiaca (Fudo et al., 1997) . The dimethyl ether isoeugenitin methyl ether is found in Colchicum decaisnei Boiss. (Al-Tel et al., 1991; Kalinin and Snieckus, 1998) and the 7-(2,3,6-tri-O-acetyl)-glucoside lobodirin in the Chilean lichen Lobodirina cerebriformis Follmann (Huneck, 1973; Huneck et al., 1992) . 9Z-octadec-9-enamide has previously been found in Desmos cochinchinensis Lour. (Sun et al., 1995) , the lichen Stereocaulon alpinum Laurer (Ingolfsdottir et al., 1997) , and the cerebrospinal fluid of humans, cats and rats (Dictionary of Natural Products, 2006) . It is reported to be a sleep inducer and to exhibit moderate activity against cyclooxygenase (Ingolfsdottir et al., 1997) .
It is noteworthy that alkaloids were not detected in either the dichloromethane or 90% methanolic extracts using Dragendorff's reagent as a conventional method of detection. Plants belonging to the family Amaryllidaceae, including some Gethyllis species, are known to be the exclusive source of Amaryllidaceae alkaloids (Viladomat et al., 1997) . However, the fact that alkaloids were not detected in G. ciliaris, in this study, does not necessarily mean that this species does not contain Amaryllidaceae alkaloids. More emphasis, in future research, needs to be paid to the ontogenic and environmental factors that affect the production of alkaloids, if any, in this species.
It is not surprising that isoeugenitol inhibited COX-1 activity. A number of studies have shown that natural products with a phenolic moiety (such as curcumin, resveratrol, and the flavonoids baicalein and cirsiliol) inhibit the COX-1 enzyme (Calixto et al., 2003) .
From the results presented, isoeugenitol has low activity when compared to the reference anti-inflammatory indomethacin. The next step is to investigate the inhibitory effect of isoeugenitol against COX-2 as the three dimensional structure of COX-2 revealed that its active site is slightly larger and can accommodate bigger structures than those which are able to fit into the active site of COX-1 (Botting, 2006) .
